Finance Gilead Sciences, Inc. (GILD)’s Breast Cancer Study Success Drives Investor Optimism Amid Broader Market SlumpMay 24, 20250 Gilead Sciences, Inc. (NASDAQ:GILD) has revealed encouraging outcomes from its ASCENT-03 scientific trial, showcasing a significant breakthrough in treating metastatic…
Finance Gilead Sciences, Inc. (GILD) and Kite to Present Breakthrough Cancer Therapy Data at 2025 ASCO and EHAMay 19, 20250 Gilead Sciences, Inc. (NASDAQ:GILD) plans to current over 20 analysis abstracts—spanning each Gilead and its cell remedy unit Kite—at two…
Finance Gilead Sciences, Moderna, Tesla and moreDecember 21, 20220 An indication is posted in entrance of the Gilead Sciences headquarters on April 29, 2020 in Foster Metropolis, California.Justin Sullivan…
